7Baggers

Kenvue Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Account Payables  
 Long-Term Debt  
 Inventory  
20230402 20230702 20231001 20231231 20240331 20240630 20240929 20241229 20250330 20250629 01.362.714.075.426.788.139.49Billion

Kenvue Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-29 2025-03-30 2024-12-29 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 
            
  assets          
  current assets          
  cash and cash equivalents1,070,000,000 1,057,000,000 1,070,000,000 1,057,000,000 1,014,000,000 1,155,000,000 1,382,000,000 1,062,000,000 1,231,000,000 1,691,000,000 
  trade receivables, less allowances for credit losses2,331,000,000 2,312,000,000 2,165,000,000 2,394,000,000 2,240,000,000 2,160,000,000 2,073,000,000 2,109,000,000 2,096,000,000 2,109,000,000 
  inventories1,776,000,000 1,680,000,000 1,591,000,000 1,820,000,000 1,849,000,000 1,884,000,000 1,851,000,000 1,885,000,000 2,026,000,000 2,222,000,000 
  prepaid expenses and other receivables525,000,000 505,000,000 494,000,000 460,000,000 557,000,000 645,000,000 567,000,000 619,000,000 643,000,000 242,000,000 
  other current assets152,000,000 156,000,000 205,000,000 210,000,000 221,000,000 253,000,000 265,000,000 219,000,000 223,000,000 175,000,000 
  total current assets5,854,000,000 5,710,000,000 5,525,000,000 5,941,000,000 5,881,000,000 6,097,000,000 6,138,000,000 5,894,000,000 6,219,000,000 6,439,000,000 
  property, plant, and equipment2,038,000,000 1,927,000,000 1,849,000,000 1,776,000,000 2,004,000,000 2,005,000,000 2,042,000,000 1,872,000,000 1,832,000,000 1,836,000,000 
  intangible assets8,804,000,000 8,586,000,000 8,474,000,000 8,887,000,000 8,762,000,000 9,378,000,000 9,619,000,000 9,487,000,000 9,678,000,000 9,837,000,000 
  goodwill9,486,000,000 9,136,000,000 8,843,000,000 9,297,000,000 8,973,000,000 9,032,000,000 9,271,000,000 8,974,000,000 9,081,000,000 9,234,000,000 
  deferred taxes on income220,000,000 199,000,000 184,000,000 228,000,000 206,000,000 171,000,000 158,000,000 156,000,000 143,000,000 168,000,000 
  other assets730,000,000 699,000,000 726,000,000 796,000,000 617,000,000 600,000,000 623,000,000 694,000,000 589,000,000 386,000,000 
  total assets27,132,000,000 26,257,000,000 25,601,000,000 26,925,000,000 26,443,000,000 27,283,000,000 27,851,000,000 27,077,000,000 27,542,000,000 35,595,000,000 
  liabilities and stockholders’ equity          
  current liabilities          
  loans and notes payable1,553,000,000 2,429,000,000 1,552,000,000 1,648,000,000 1,427,000,000 1,522,000,000 599,000,000 513,000,000 752,000,000  
  accounts payable2,568,000,000 2,332,000,000 2,254,000,000 2,274,000,000 2,437,000,000 2,602,000,000 2,489,000,000 2,281,000,000 2,354,000,000 1,781,000,000 
  accrued liabilities1,081,000,000 1,007,000,000 1,132,000,000 1,164,000,000 1,262,000,000 1,083,000,000 1,456,000,000 1,288,000,000 1,201,000,000 987,000,000 
  accrued rebates, returns, and promotions697,000,000 744,000,000 727,000,000 697,000,000 715,000,000 795,000,000 795,000,000 696,000,000 753,000,000 838,000,000 
  accrued taxes on income89,000,000 154,000,000 74,000,000 163,000,000 96,000,000 164,000,000 142,000,000 383,000,000 239,000,000 604,000,000 
  total current liabilities5,988,000,000 6,666,000,000 5,739,000,000 5,946,000,000 5,937,000,000 6,166,000,000 5,481,000,000 5,161,000,000 5,299,000,000 4,210,000,000 
  long-term debt7,057,000,000 6,309,000,000 7,055,000,000 7,053,000,000 7,051,000,000 7,033,000,000 7,687,000,000 7,685,000,000 7,684,000,000 7,676,000,000 
  employee-related obligations371,000,000 350,000,000 342,000,000 362,000,000       
  other liabilities606,000,000 559,000,000 536,000,000 542,000,000 535,000,000 541,000,000 491,000,000 569,000,000 593,000,000 516,000,000 
  total liabilities16,402,000,000 16,204,000,000 15,933,000,000 16,281,000,000 16,265,000,000 16,662,000,000 16,640,000,000 16,184,000,000 16,502,000,000 15,313,000,000 
  commitments and contingencies          
  stockholders’ equity          
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of june 29, 2025 and december 29, 2024          
  common stock19,000,000 19,000,000 19,000,000 19,000,000 19,000,000 19,000,000 19,000,000 19,000,000 19,000,000  
  additional paid-in capital16,288,000,000 16,201,000,000 16,130,000,000 16,098,000,000 16,075,000,000 16,033,000,000 16,147,000,000 16,131,000,000 16,098,000,000  
  treasury stock-369,000,000 -305,000,000 -242,000,000 -121,000,000 -98,000,000 -98,000,000 -7,000,000    
  accumulated deficit-136,000,000 -163,000,000         
  accumulated other comprehensive loss-5,072,000,000 -5,699,000,000 -6,146,000,000 -5,359,000,000 -5,835,000,000 -5,675,000,000 -5,377,000,000 -5,742,000,000 -5,507,000,000 -5,239,000,000 
  total stockholders’ equity10,730,000,000 10,053,000,000 9,668,000,000        
  total liabilities and stockholders’ equity27,132,000,000 26,257,000,000 25,601,000,000        
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of march 30, 2025 and december 29, 2024          
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of december 29, 2024 and december 31, 2023          
  (accumulated deficit) retained earnings  -93,000,000        
  liabilities and equity          
  equity          
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of september 29, 2024 and december 31, 2023          
  retained earnings   7,000,000 17,000,000 342,000,000 429,000,000 485,000,000 430,000,000  
  total equity   10,644,000,000 10,178,000,000 10,621,000,000 11,211,000,000 10,893,000,000 11,040,000,000 20,282,000,000 
  total liabilities and equity   26,925,000,000 26,443,000,000 27,283,000,000 27,851,000,000 27,077,000,000 27,542,000,000 35,595,000,000 
  employee related obligations    350,000,000 354,000,000 360,000,000 254,000,000 244,000,000 228,000,000 
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of june 30, 2024 and december 31, 2023          
  preferred stock, 0.01 par value, 750,000 shares authorized; no shares issued and outstanding as of march 31, 2024 and december 31, 2023          
  preferred stock, 0.01 par value, 750,000 shares authorized, no shares issued and outstanding as of december 31, 2023          
  net investment from johnson & johnson          
  preferred stock, 0.01 par value, 750 shares authorized, no shares issued and outstanding          
  net investment from parent         25,521,000,000 
  restricted cash         7,695,000,000 

We provide you with 20 years of balance sheets for Kenvue stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kenvue. Explore the full financial landscape of Kenvue stock with our expertly curated balance sheets.

The information provided in this report about Kenvue stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.